Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) Director David Pyott sold 3,830 shares of Alnylam Pharmaceuticals stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $299.18, for a total value of $1,145,859.40. Following the sale, the director directly owned 1,582 shares in the company, valued at […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) Director Spencer Berthelsen sold 8,000 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $75.67, for a total value of $605,360.00. Following the transaction, the director owned 156,013 shares in the company, valued at $11,805,503.71. […]

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ – Get Free Report) Director Heather Ann Mcsharry sold 2,000 shares of Jazz Pharmaceuticals stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $241.00, for a total transaction of $482,000.00. Following the sale, the director owned 18,449 shares in the company, valued at […]